{
    "organizations": [],
    "uuid": "43e9b6f8968646134ebccd86f5c534f8cb334a1f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-otcpharm-board-approves-terminatin/brief-otcpharm-board-approves-terminating-public-status-of-company-idUSFWN1RU15G",
    "ord_in_thread": 0,
    "title": "BRIEF-OTCPharm Board Approves Terminating Public Status Of Company",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - OTCPharm PAO:\n* SAYS BOARD APPROVES TERMINATING PUBLIC STATUS OF COMPANY * SAYS SHAREHOLDERS OPPOSING DECISION CAN BUY-BACK SHARES AT RUB 202 PER SHARE Source text: bit.ly/2HatYA0\nFurther company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-18T00:13:00.000+03:00",
    "crawled": "2018-04-18T18:10:51.027+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "otcpharm",
        "pao",
        "say",
        "board",
        "approves",
        "terminating",
        "public",
        "status",
        "company",
        "say",
        "shareholder",
        "opposing",
        "decision",
        "share",
        "rub",
        "per",
        "share",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}